Valeant Pharmaceuticals International (NYSE:VRX)

CAPS Rating: 3 out of 5

A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology.

Recs

0
Player Avatar gatzbp (77.23) Submitted: 8/18/2011 1:26:05 PM : Outperform Start Price: $39.87 VRX Score: +11.39

I like picking up healthcare after this pullback. Good model of cost cutting which should work regardless of who is in power in the government.

Featured Broker Partners


Advertisement